JinkoSolar Holding Company Limited And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – JinkoSolar Holding Company Limited (JKS), iRadimed Corporation (IRMD), Wintrust Financial Corporation (WTFC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. JinkoSolar Holding Company Limited (JKS)

57.1% sales growth and 10.71% return on equity

JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products. The company offers solar modules, silicon wafers, solar cells, recovered silicon materials, and silicon ingots. It also provides solar system integration services; and develops commercial solar power projects. The company sells its products to distributors, project developers, and system integrators; and utility, commercial, and residential customers under the JinkoSolar brand, as well as on an original equipment manufacturer basis. As of December 31, 2019, it had an integrated annual capacity of 15.0 gigawatt (GW) for silicon wafers, including 11.5 GW for mono wafers; 10.6 GW for solar cells; and 16.0 GW for solar modules. The company has operations in the People's Republic of China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and internationally. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.

Earnings Per Share

As for profitability, JinkoSolar Holding Company Limited has a trailing twelve months EPS of $3.94.

PE Ratio

JinkoSolar Holding Company Limited has a trailing twelve months price to earnings ratio of 11.11. Meaning, the purchaser of the share is investing $11.11 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.71%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 58%, now sitting on 91.69B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

JinkoSolar Holding Company Limited’s EBITDA is 0.09.

2. iRadimed Corporation (IRMD)

18.3% sales growth and 21.67% return on equity

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

Earnings Per Share

As for profitability, iRadimed Corporation has a trailing twelve months EPS of $1.09.

PE Ratio

iRadimed Corporation has a trailing twelve months price to earnings ratio of 44.49. Meaning, the purchaser of the share is investing $44.49 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.67%.

Volume

Today’s last reported volume for iRadimed Corporation is 28284 which is 20.89% below its average volume of 35753.

Moving Average

iRadimed Corporation’s worth is way above its 50-day moving average of $42.20 and way above its 200-day moving average of $34.72.

Yearly Top and Bottom Value

iRadimed Corporation’s stock is valued at $48.49 at 06:22 EST, under its 52-week high of $49.30 and way higher than its 52-week low of $26.00.

3. Wintrust Financial Corporation (WTFC)

13.4% sales growth and 11.83% return on equity

Wintrust Financial Corporation operates as a financial holding company. It operates in three segments: Community Banking, Specialty Finance, and Wealth Management. The Community Banking segment offers non-interest bearing deposits, non-brokered interest-bearing transaction accounts, and savings and domestic time deposits; home equity, consumer, and real estate loans; safe deposit facilities; and automatic teller machine (ATM), online and mobile banking, and other services. It also engages in the retail origination and purchase of residential mortgages for sale into the secondary market; and provision of lending, deposits, and cash management services to condominium, homeowner, and community associations, as well as asset-based lending for middle-market companies. In addition, this segment offers loan and deposit services to mortgage brokerage companies; lending to restaurant franchisees; direct leasing; small business administration loans; commercial mortgages and construction loans; and financial solutions. It provides personal and commercial banking services primarily to individuals, small to mid-sized businesses, local governmental units, and institutional clients. The Specialty Finance segment offers commercial and life insurance premiums financing for businesses and individuals; accounts receivable financing, value-added, and out-sourced administrative services; and other specialty finance services, as well as data processing of payrolls, billing, and cash management services to temporary staffing industry. The Wealth Management segment provides trust and investment, asset management, tax-deferred exchange, securities brokerage, and retirement plan services. The company operates 181 banking facilities and 229 ATMs in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and Florida. Wintrust Financial Corporation was founded in 1991 and is headquartered in Rosemont, Illinois.

Earnings Per Share

As for profitability, Wintrust Financial Corporation has a trailing twelve months EPS of $8.56.

PE Ratio

Wintrust Financial Corporation has a trailing twelve months price to earnings ratio of 7.07. Meaning, the purchaser of the share is investing $7.07 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.83%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 2.58%.

4. FactSet Research Systems (FDS)

7.8% sales growth and 31.72% return on equity

FactSet Research Systems Inc., a financial data and analytics company, provides integrated financial information and analytical applications to the investment community in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company delivers insight and information through the workflow solutions of research, analytics and trading, content and technology solutions, and wealth. It serves portfolio managers, investment banks, asset managers, wealth advisors, corporate clients, and other financial services entities. FactSet Research Systems Inc. was founded in 1978 and is headquartered in Norwalk, Connecticut.

Earnings Per Share

As for profitability, FactSet Research Systems has a trailing twelve months EPS of $11.57.

PE Ratio

FactSet Research Systems has a trailing twelve months price to earnings ratio of 34.24. Meaning, the purchaser of the share is investing $34.24 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.72%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 4.5% and positive 12.1% for the next.

Yearly Top and Bottom Value

FactSet Research Systems’s stock is valued at $396.19 at 06:22 EST, way under its 52-week high of $474.13 and way higher than its 52-week low of $345.92.

Volume

Today’s last reported volume for FactSet Research Systems is 213801 which is 14.24% below its average volume of 249315.

Earnings Before Interest, Taxes, Depreciation, and Amortization

FactSet Research Systems’s EBITDA is 8.78.

5. Addus HomeCare Corporation (ADUS)

7.1% sales growth and 8.14% return on equity

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Earnings Per Share

As for profitability, Addus HomeCare Corporation has a trailing twelve months EPS of $3.12.

PE Ratio

Addus HomeCare Corporation has a trailing twelve months price to earnings ratio of 28.66. Meaning, the purchaser of the share is investing $28.66 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.14%.

Yearly Top and Bottom Value

Addus HomeCare Corporation’s stock is valued at $89.41 at 06:22 EST, way below its 52-week high of $114.99 and way higher than its 52-week low of $73.66.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 11% and 11.7%, respectively.

6. Citigroup (C)

5.7% sales growth and 7.61% return on equity

Citigroup Inc., a diversified financial services holding company, provides various financial products and services to consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. It operates through three segments: Institutional Clients Group (ICG), Personal Banking and Wealth Management (PBWM), and Legacy Franchises. The ICG segment offers wholesale banking products and services, including fixed income and equity sales and trading, foreign exchange, prime brokerage, derivative, equity and fixed income research, corporate lending, investment banking and advisory, private banking, cash management, trade finance, and securities services to corporate, institutional, and public sector clients. The PBWM segment offers traditional banking services to retail and small business customers through retail banking, cash, rewards, value portfolios, and co-branded cards. It also provides various banking, credit cards, custody, trust, mortgages, home equity, small business, and personal consumer loans. The Legacy Franchises segment provides traditional retail banking and branded card products to retail and small business customers. The company was founded in 1812 and is headquartered in New York, New York.

Earnings Per Share

As for profitability, Citigroup has a trailing twelve months EPS of $7.28.

PE Ratio

Citigroup has a trailing twelve months price to earnings ratio of 6.13. Meaning, the purchaser of the share is investing $6.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.61%.

Previous days news about Citigroup(C)

  • According to Zacks on Thursday, 25 May, "Apart from HSBC, Citigroup (C Quick QuoteC – Free Report) is another major global bank undertaking restructuring operations by exiting less profitable markets. ", "These efforts are expected to free up capital, which Citigroup will likely invest in wealth management operations in Singapore, Hong Kong, the UAE and London to stoke growth."
  • Citigroup (c) plans Mexico banamex ipo, to resume buybacks in Q2. According to Zacks on Thursday, 25 May, "More than a year after announcing plans to exit its consumer, small business and middle-market banking operations in Mexico - Banco Nacional de México ("Banamex"), Citigroup Inc. (C Quick QuoteC – Free Report) has decided to pursue an initial public offering (IPO) of the business.", "Since the announcement of the broader strategic actions to exit consumer banking across 14 markets in Asia, Europe, the Middle East and Mexico, Citigroup has signed deals to divest consumer businesses in nine markets and completed sales in seven markets, including Australia, Bahrain, Malaysia, the Philippines, Thailand, Vietnam and India."
  • According to Zacks on Thursday, 25 May, "As Citigroup continues to work through its legacy legal issues, we believe that the company might witness elevated regulatory expenses and litigation provisions, hurting its financials in the near term.", "Similarly, Citigroup continues to encounter many investigations and lawsuits from investors and regulators. "

Leave a Reply

Your email address will not be published. Required fields are marked *